Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i>

<table class="table-group" id="tab5"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left" rowspan="2">Cell lines</td><td class="align_center" colspan="3">Vimentin/<i>β</i>-actin</td></tr><tr class="thead"><td class="align_center">Normoxic</td><td class="align_center">Hypoxic</td><td class="align_center">Hypoxic + propofol</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">PC3</td><td class="align_center">0.2797</td><td class="align_center">1.436738</td><td class="align_center">0.685475</td></tr><tr><td class="align_left">DU145</td><td class="align_center">0.128068</td><td class="align_center">0.335682</td><td class="align_center">0.154392</td></tr><tr><td class="align_left">22RV1</td><td class="align_center">0.071099</td><td class="align_center">0.741434</td><td class="align_center">0.109708</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

The grey value of the vimentin protein treated with or without propofol under normoxia or hypoxia conditions.

BioMed Research International

tab5

Table 5

Table 5: Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1<i>α</i> 

Table 5 | Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial–Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1α 